Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,083
-$180 QoQ
Shares Held
45
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,804
of 2,821 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Eukles Asset Management holds $4,968,554 across 5 Drug Manufacturers - General names. PFE ranks #5 (0.0% of the industry book) .
All Filings in PFE
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,083 | 45 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,263 | 45 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,120 | 45 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,146 | 45 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,090 | 45 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,140 | 45 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,193 | 45 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $1,302 | 45 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,259 | 45 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,248 | 45 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,295 | 45 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,492 | 45 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $1,650 | 45 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,836 | 45 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $2 | 45 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,969 | 45 | Shares | Sole | 2022-10-28 | |
| No filing history on record for this holder in this stock. | ||||||